Literature DB >> 639426

Hexobarbital disposition in compensated and decompensated cirrhosis of the liver.

W Zilly, D D Breimer, E Richter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 639426     DOI： 10.1002/cpt1978235525

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 2.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

3.  Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.

Authors:  N P Vermeulen; C T Rietveld; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

4.  Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis.

Authors:  R J Royer; M J Royer-Morrot; F Paille; D Barrucand; J Schmitt; R Defrance; C Salvadori
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

5.  Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.

Authors:  G Heinemeyer; H J Gramm; W Simgen; R Dennhardt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.

Authors:  U Breyer-Pfaff; H Seyfert; M Weber; E H Egberts
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents.

Authors:  E Richter; D D Breimer; W Zilly
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

8.  Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.

Authors:  R H Barbhaiya; U A Shukla; M Pfeffer; K A Pittman; R Shrotriya; C Laroudie; R E Gammans
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Altered disposition and availability of cimetidine in liver cirrhotic patients.

Authors:  R Gugler; B Müller-Liebenau; A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

Review 10.  Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1985-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.